JP2023511382A5 - - Google Patents

Info

Publication number
JP2023511382A5
JP2023511382A5 JP2022544318A JP2022544318A JP2023511382A5 JP 2023511382 A5 JP2023511382 A5 JP 2023511382A5 JP 2022544318 A JP2022544318 A JP 2022544318A JP 2022544318 A JP2022544318 A JP 2022544318A JP 2023511382 A5 JP2023511382 A5 JP 2023511382A5
Authority
JP
Japan
Prior art keywords
brain
human
human subject
expression vector
idua
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022544318A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023511382A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/014129 external-priority patent/WO2021150570A1/en
Publication of JP2023511382A publication Critical patent/JP2023511382A/ja
Publication of JP2023511382A5 publication Critical patent/JP2023511382A5/ja
Priority to JP2026019056A priority Critical patent/JP2026097826A/ja
Pending legal-status Critical Current

Links

JP2022544318A 2020-01-22 2021-01-20 完全ヒトグリコシル化ヒトα-L-イズロニダーゼ(IDUA)を用いたムコ多糖症I型の治療 Pending JP2023511382A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026019056A JP2026097826A (ja) 2020-01-22 2026-02-09 完全ヒトグリコシル化ヒトα-L-イズロニダーゼ(IDUA)を用いたムコ多糖症I型の治療

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202062964351P 2020-01-22 2020-01-22
US62/964,351 2020-01-22
US202063086145P 2020-10-01 2020-10-01
US63/086,145 2020-10-01
PCT/US2021/014129 WO2021150570A1 (en) 2020-01-22 2021-01-20 Treatment of mucopolysaccharidosis i with fully-human glycosylated human alpha-l-iduronidase (idua)

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026019056A Division JP2026097826A (ja) 2020-01-22 2026-02-09 完全ヒトグリコシル化ヒトα-L-イズロニダーゼ(IDUA)を用いたムコ多糖症I型の治療

Publications (2)

Publication Number Publication Date
JP2023511382A JP2023511382A (ja) 2023-03-17
JP2023511382A5 true JP2023511382A5 (cg-RX-API-DMAC7.html) 2024-02-16

Family

ID=74592808

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022544318A Pending JP2023511382A (ja) 2020-01-22 2021-01-20 完全ヒトグリコシル化ヒトα-L-イズロニダーゼ(IDUA)を用いたムコ多糖症I型の治療
JP2026019056A Pending JP2026097826A (ja) 2020-01-22 2026-02-09 完全ヒトグリコシル化ヒトα-L-イズロニダーゼ(IDUA)を用いたムコ多糖症I型の治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026019056A Pending JP2026097826A (ja) 2020-01-22 2026-02-09 完全ヒトグリコシル化ヒトα-L-イズロニダーゼ(IDUA)を用いたムコ多糖症I型の治療

Country Status (9)

Country Link
US (1) US20230059395A1 (cg-RX-API-DMAC7.html)
EP (1) EP4093428A1 (cg-RX-API-DMAC7.html)
JP (2) JP2023511382A (cg-RX-API-DMAC7.html)
KR (1) KR20220131522A (cg-RX-API-DMAC7.html)
AU (1) AU2021211416A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022014563A2 (cg-RX-API-DMAC7.html)
CA (1) CA3167685A1 (cg-RX-API-DMAC7.html)
IL (1) IL294625A (cg-RX-API-DMAC7.html)
WO (1) WO2021150570A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3068328A1 (en) 2017-07-06 2019-01-10 The Trustees Of The University Of Pennsylvania Aav9-mediated gene therapy for treating mucopolysaccharidosis type i
EP3684938A1 (en) 2017-09-22 2020-07-29 The Trustees of the University of Pennsylvania Gene therapy for treating mucopolysaccharidosis type ii
US20230088992A1 (en) * 2020-01-29 2023-03-23 Regenxbio Inc. Treatment of mucopolysaccharidosis ii with recombinant human iduronate-2-sulfatase (ids) produced by human neural or glial cells

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596535B1 (en) 1999-08-09 2003-07-22 Targeted Genetics Corporation Metabolically activated recombinant viral vectors and methods for the preparation and use
CN103589692B (zh) 2001-11-13 2018-07-24 宾夕法尼亚大学托管会 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
DK2359869T3 (en) 2001-12-17 2019-04-15 Univ Pennsylvania Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
EP1668143B1 (en) 2003-09-30 2013-03-20 The Trustees of The University of Pennsylvania Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
DE23193606T1 (de) 2005-04-07 2024-02-15 The Trustees Of The University Of Pennsylvania Verfahren zur erhöhung der funktion eines aav-vektors
JP4495210B2 (ja) 2005-06-09 2010-06-30 パナソニック株式会社 振幅誤差補償装置及び直交度誤差補償装置
US8734809B2 (en) 2009-05-28 2014-05-27 University Of Massachusetts AAV's and uses thereof
US8927514B2 (en) 2010-04-30 2015-01-06 City Of Hope Recombinant adeno-associated vectors for targeted treatment
US8628966B2 (en) 2010-04-30 2014-01-14 City Of Hope CD34-derived recombinant adeno-associated vectors for stem cell transduction and systemic therapeutic gene transfer
US10738326B2 (en) 2010-10-27 2020-08-11 Jichi Medical University Adeno-associated virus vector for gene transfer to nervous system cells
CA2826273C (en) 2011-02-10 2021-11-02 The University Of North Carolina At Chapel Hill Viral vectors with modified transduction profiles and methods of making and using the same
DK3693025T3 (da) 2011-04-22 2022-01-10 Univ California Adenoassocierede virus-virioner med variant capsid og fremgangsmåder til anvendelse heraf
EP3795581A3 (en) 2011-08-24 2021-06-09 The Board of Trustees of the Leland Stanford Junior University New avv capsid proteins for nucleic acid transfer
EP3470523A1 (en) 2012-05-09 2019-04-17 Oregon Health & Science University Adeno associated virus plasmids and vectors
EP2970946A4 (en) 2013-03-13 2016-09-07 Philadelphia Children Hospital ADENOASSOZED VIRUS VECTORS AND METHOD FOR USE THEREOF
EP3564379A1 (en) 2013-09-13 2019-11-06 California Institute of Technology Selective recovery
HUE052676T2 (hu) 2013-10-11 2021-05-28 Massachusetts Eye & Ear Infirmary Eljárások õsi vírusszekvenciák elõrejelzésére és alkalmazásaik
US10746742B2 (en) 2014-04-25 2020-08-18 Oregon Health & Science University Methods of viral neutralizing antibody epitope mapping
MA43968A (fr) * 2016-02-03 2018-12-12 Univ Pennsylvania Thérapie génique pour traiter la mucopolysaccharidose de type i
JP7042814B2 (ja) * 2016-11-01 2022-03-28 日本光電工業株式会社 患者の頭部に配置されて当該患者の脳の皮質組織の脈動を測定するためのトランスデューサを含むシステム
IL309808B2 (en) * 2016-11-15 2025-04-01 Univ Minnesota Method for improving neurological function in MPSI and MPSII and other neurological disorders
JP2020508289A (ja) * 2017-01-31 2020-03-19 レジェンクスバイオ インコーポレーテッド 完全ヒトグリコシル化ヒトα−L−イズロニダーゼ(IDUA)を用いたムコ多糖症I型の治療
CA3068328A1 (en) * 2017-07-06 2019-01-10 The Trustees Of The University Of Pennsylvania Aav9-mediated gene therapy for treating mucopolysaccharidosis type i

Similar Documents

Publication Publication Date Title
JP7308000B2 (ja) Vegf-aポリペプチドをコードする改変rnaを送達するための脂質ナノ粒子
Xu et al. Rosuvastatin treatment activates JAK-STAT pathway and increases efficacy of allogeneic mesenchymal stem cell transplantation in infarcted hearts
JP2020508289A5 (cg-RX-API-DMAC7.html)
Vallières et al. Influence of interleukin‐6 on neural activity and transcription of the gene encoding corticotrophin‐releasing factor in the rat brain: an effect depending upon the route of administration
JP2024540994A5 (cg-RX-API-DMAC7.html)
Zhao et al. Targeting l‐selectin lymphocytes to deliver immunosuppressive drug in lymph nodes for durable multiple sclerosis treatment
Weinstock-Guttman et al. Treatment of fulminant multiple sclerosis with intravenous cyclophosphamide
JP6026659B2 (ja) 神経成長因子が中高年男性の性機能低下症候群を治療するための薬物の調製における応用
JP2021531276A5 (cg-RX-API-DMAC7.html)
CN107250360B (zh) c-Rel特异性siRNA及其用于防治自身免疫性银屑病的应用
JP2022537555A5 (cg-RX-API-DMAC7.html)
Segura-Ulate et al. FTY720-derivatives do not induce FTY720-like lymphopenia
CN115624543A (zh) 治疗偏头痛的药物、药物组合物、其制备方法和制药用途
CN107260723B (zh) 5Z-7-oxozeaenol在制备治疗自身免疫性脑脊髓炎药物中的应用
CN118924875A (zh) 药物组合物在治疗偏头痛上的应用
WO2020227690A1 (en) Methods of using lipid nanoparticles for delivering modified rna encoding a vegf-a polypeptide and pharmaceutical compositions comprising the same
Uemura et al. The protective effect of interleukin-11 on the cell death induced by X-ray irradiation in cultured intestinal epithelial cell
CN112190708A (zh) 趋化因子受体ccr6抑制剂在预防银屑病复发中的新应用
CN118634324B (zh) GCA-NAb单克隆抗体在制备预防和/或治疗肺纤维化药物中的应用
US11299537B2 (en) Methods for treatment of motor neuron diseases
CN114984074B (zh) 一种人参总蛋白的制备方法及其改善帕金森病的应用
Gul et al. Safe, Rapid-Onset, and Sustained Biological Activity of IL-1beta Regulating Antibody XOMA 052 in Resistant Uveitis of Behçet’s Disease: Preliminary Results of a Pilot Trial
US11617729B2 (en) Uses of guanidine hydrochloride as a drug for treating cancers/tumors
CN120392989A (zh) 一种用于多发性硬化症治疗的耐受原疫苗及其制备方法和应用
CN102274194A (zh) 一种含托烷司琼化合物的药物组合物及其制备方法